RANI THERAPEUTICS

Serial Number 87418734
Registration 5633654
702

Registration Progress

Application Filed
Apr 20, 2017
Under Examination
Oct 24, 2017
Approved for Publication
Aug 29, 2017
Published for Opposition
Aug 29, 2017
Registered
Dec 18, 2018

Trademark Image

RANI THERAPEUTICS

Basic Information

Serial Number
87418734
Registration Number
5633654
Filing Date
April 20, 2017
Registration Date
December 18, 2018
Published for Opposition
August 29, 2017
Drawing Code
4

Status Summary

Current Status
Active
Status Code
702
Status Date
Jan 29, 2025
Registration
Registered
Classes
005 010

Rights Holder

Rani Therapeutics, LLC

16
Address
2051 Ringwood Ave.
San Jose, CA 95131

Ownership History

Rani Therapeutics, LLC

Original Applicant
16
San Jose, CA

Rani Therapeutics, LLC

Owner at Publication
16
San Jose, CA

Rani Therapeutics, LLC

Original Registrant
16
San Jose, CA

Legal Representation

Attorney
Mary Margaret L. O'Donnell

USPTO Deadlines

Next Deadline
1097 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20181218)
Due Date
December 18, 2028
Grace Period Ends
June 18, 2029

Application History

28 events
Date Code Type Description Documents
Jan 29, 2025 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Jan 29, 2025 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Jan 29, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Sep 11, 2024 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Dec 18, 2023 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Dec 18, 2018 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 13, 2018 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Nov 12, 2018 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Oct 13, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 12, 2018 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Oct 3, 2018 IUAF S USE AMENDMENT FILED Loading...
Oct 12, 2018 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 3, 2018 EXT2 S SOU EXTENSION 2 FILED Loading...
Oct 12, 2018 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Oct 3, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 3, 2018 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Feb 2, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 31, 2018 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 31, 2018 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 31, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 24, 2017 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 29, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 29, 2017 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 9, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 20, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 15, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 26, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 24, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Ingestible drug delivery agents in the form of capsules to facilitate delivery of pharmaceuticals
First Use Anywhere: Feb 21, 2012
First Use in Commerce: Aug 15, 2018
Class 010
Ingestible devices that can be programmed to release medication doses for medical, dental or veterinary use; ingestible devices for use in medical diagnosis and treatment
First Use Anywhere: Feb 21, 2012
First Use in Commerce: Aug 15, 2018

Classification

International Classes
005 010

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"